Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.05405 | 44 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.44286 | 18 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.0494 | 45 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.56719 | 60 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.02179 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.43876 | 16 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.37919 | 14 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.38579 | 16 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.31737 | 14 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.77487 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.05769 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16116 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.30651 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.86445 | 65 |